Related Experiment Video
Updated: May 16, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
AMP-dependent hypothermia affords protection from ischemic brain injury
Mirko Muzzi1, Francesco Blasi, Alberto Chiarugi
1Department of Preclinical and Clinical Pharmacology University of Florence, Florence, Italy. mirko.muzzi@unifi.it
Abstract:
In light of the relevance of therapeutic hypothermia to stroke treatment, we investigated whether 5'-adenosine monophosphate (AMP)-dependent cooling affords protection from ischemic brain injury. We show that hypothermia by AMP is because of adenosine A1 receptor (A1R) activation and is not invariantly associated with hypotension. Inhibition of ecto-5'-nucleotidase-dependent constitutive degradation of brain extracellular AMP by methylene-ADP (AMPCP) also suffices to prompt A1R-dependent hypothermia without hypotension. Both intraischemic and postischemic hypothermia by AMP or AMPCP reduce infarct volumes and mortality of mice subjected to transient middle cerebral artery occlusion. Data disclose that AMP-dependent hypothermia is of therapeutic relevance to treatment of brain ischemia.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Cytotoxic Edema: Pathophysiology

